Literature DB >> 18798224

Effects of choline-deprivation on paracetamol- or phenobarbital-induced rat liver metabolic response.

Maria Konstandi1, Dimitrios Segos, Panagiota Galanopoulou, Stamatios Theocharis, Apostolos Zarros, Matti A Lang, Marios Marselos, Charis Liapi.   

Abstract

Choline is an essential nutrient that seems to be involved in a wide variety of metabolic reactions and functions in both humans and rodents. Various pathophysiological states have been linked to choline deprivation (CD). The aim of the present study was to determine the effect of CD upon biochemical, histological and metabolic alterations induced by drugs that affect hepatic functional integrity and various drug metabolizing systems via distinct mechanisms. For this purpose, paracetamol (ACET) or phenobarbital (PB) were administered to male Wistar rats that were fed with standard rodent chow (normally fed, NF) or underwent dietary CD. The administration of ACET increased the serum aspartate aminotransferase levels in NF rats, while CD restricted this increase. On the other hand, ACET suppressed alkaline phosphatase levels only in CD rats. Moreover, CD prevented the PB-induced increase of the mitotic activity of hepatocytes. The administration of ACET down-regulated CYP1A2 and CYP2B1 expression in CD rats, while up-regulating them in NF rats. The administration of PB suppressed CYP1A2 apoprotein levels in CD rats, whereas the drug had no effect on NF rats. The PB-induced up-regulation of CYP2B, CYP2E1 and CYP1A1 isozymes was markedly higher in CD than in NF rats. In addition, PB increased glutathione-S-transferase activity only in CD rats. Hepatic glutathione content (GSH) was suppressed by ACET in NF rats, whereas the drug increased GSH in CD rats. Our data suggest that CD has a significant impact on the hepatic metabolic functions, and in particular on those related to drug metabolism. Thus, CD may modify drug effectiveness and toxicity, as well as drug-drug interactions, particularly those related to ACET and PB.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 18798224     DOI: 10.1002/jat.1386

Source DB:  PubMed          Journal:  J Appl Toxicol        ISSN: 0260-437X            Impact factor:   3.446


  3 in total

1.  Hepatic injury due to combined choline-deprivation and thioacetamide administration: an experimental approach to liver diseases.

Authors:  Hussam Al-Humadi; Stamatios Theocharis; Ismene Dontas; Vasileios Stolakis; Apostolos Zarros; Argyro Kyriakaki; Rafal Al-Saigh; Charis Liapi
Journal:  Dig Dis Sci       Date:  2012-07-10       Impact factor: 3.199

2.  Choline-deprivation alters crucial brain enzyme activities in a rat model of diabetic encephalopathy.

Authors:  Charis Liapi; Argyro Kyriakaki; Apostolos Zarros; Panagiota Galanopoulou; Hussam Al-Humadi; Ismene Dontas; Konstantinos Voumvourakis; Stylianos Tsakiris
Journal:  Metab Brain Dis       Date:  2010-09-14       Impact factor: 3.584

3.  Combined thirty-day exposure to thioacetamide and choline-deprivation alters serum antioxidant status and crucial brain enzyme activities in adult rats.

Authors:  Charis Liapi; Hussam Al-Humadi; Apostolos Zarros; Panagiota Galanopoulou; Vasileios Stolakis; Elena Gkrouzman; Zois Mellios; Nikolina Skandali; Foteini Anifantaki; Stylianos Tsakiris
Journal:  Metab Brain Dis       Date:  2009-08-21       Impact factor: 3.584

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.